1 Min Read
Oct 17 (Reuters) - Granules India Ltd
* Granules India's Gagillapur facility successfully completed us fda inspection Source text: bit.ly/2dUN37Z Further company coverage: (Bengaluru newsroom)
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.